CXCL10 Involvement in Vestibular Migraine via the PI3K / AKT Signaling Pathway
CNS Neuroscience & Therapeutics · 2025-11 · 31 (11)
DOI: 10.1111/cns.70655 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 17.11.2025. Verfasst von Mao-Mei Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Headache Center, The First Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Chemokine CXCL10, Signal Transduction, Proto-Oncogene Proteins c-akt, Migraine Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Applied Basic Research Program.
Abstract (Originalsprache)
Aims
C‐X‐C motif chemokine ligand 10 (CXCL10) is a member of the CXC chemokine family, known as a classical pain‐related chemokine. While CXCL10 is implicated in neuropathic pain, its role in vestibular migraine (VM) remains unclear.
Methods
Serum CXCL10 levels correlated with dizziness and headache severity in VM patients. In the rat VM model, CXCL10, C‐X‐C motif chemokine receptor 3 (CXCR3), and phosphatidylinositol 4,5‐bisphosphate 3‐kinase (PI3K)/protein kinase B (AKT) signaling pathway expression were evaluated to explore the potential mechanisms of CXCL10 in VM.
Results
Serum CXCL10 levels in VM patients were significantly elevated and positively correlated with headache and dizziness severity. In the rat VM model, CXCL10 and CXCR3 expression in the trigeminal nucleus caudalis and vestibular nuclei were significantly increased. Additionally, molecules related to the PI3K/AKT signaling pathway and downstream inflammatory factors showed significantly elevated expression.
Conclusion
CXCL10 activates the PI3K/AKT signaling pathway, promoting the release of inflammatory factors, including interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α, and is thus involved in the pathogenesis of VM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Headache Center, The First Hospital of Shanxi Medical University, Taiyuan, China.
- Department of Neurology, Headache Center, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, China.
ORCID-Profile: Mao-Mei Song, Ting-Yan Chen, Ying-Jie Gao, Chang-Xin Li, Sui-Yi Xu
Förderung
- Shanxi Applied Basic Research Program
Zitieren
APA
Song, M. M., Chen, T. Y., Song, S. N., Gao, Y. J., Li, C. X., & Xu, S. Y. (2025). CXCL10 Involvement in Vestibular Migraine via the PI3K / AKT Signaling Pathway. CNS Neuroscience & Therapeutics, 31(11). https://doi.org/10.1111/cns.70655
Vancouver
Song MM, Chen TY, Song SN, Gao YJ, Li CX, Xu SY. CXCL10 Involvement in Vestibular Migraine via the PI3K / AKT Signaling Pathway. CNS Neuroscience & Therapeutics. 2025;31(11). doi:10.1111/cns.70655
BibTeX
@article{Song2025,
author = {Song, Mao-Mei and Chen, Ting-Yan and Song, Shi-Na and Gao, Ying-Jie and Li, Chang-Xin and Xu, Sui-Yi},
title = {CXCL10 Involvement in Vestibular Migraine via the PI3K / AKT Signaling Pathway},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {11},
doi = {10.1111/cns.70655}
}
EUVIMED